These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 1902388)

  • 1. Results of long-term rice bran treatment on stone recurrence in hypercalciuric patients.
    Ebisuno S; Morimoto S; Yasukawa S; Ohkawa T
    Br J Urol; 1991 Mar; 67(3):237-40. PubMed ID: 1902388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rice-bran treatment for calcium stone formers with idiopathic hypercalciuria.
    Ebisuno S; Morimoto S; Yoshida T; Fukatani T; Yasukawa S; Ohkawa T
    Br J Urol; 1986 Dec; 58(6):592-5. PubMed ID: 3801813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rice bran treatment for patients with hypercalciuric stones: experimental and clinical studies.
    Ohkawa T; Ebisuno S; Kitagawa M; Morimoto S; Miyazaki Y; Yasukawa S
    J Urol; 1984 Dec; 132(6):1140-5. PubMed ID: 6094846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical studies on the recurrence of urolithiasis: (1). Influence of diet on urinary excretion of the stone forming constituents].
    Murayama T; Taguchi H
    Hinyokika Kiyo; 1987 Sep; 33(9):1321-30. PubMed ID: 3434487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary magnesium and oxalic acid excretion in patients with recurrent oxalate urolithiasis.
    Takasaki E
    Invest Urol; 1975 Jan; 12(4):251-4. PubMed ID: 1112654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical studies of the recurrence of urolithiasis (3). Influence of sodium intake on urinary excretion of calcium, uric acid, oxalate, phosphate and magnesium].
    Murayama T; Taguchi H
    Hinyokika Kiyo; 1988 Sep; 34(9):1537-41. PubMed ID: 3213789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Rice bran in the treatment of idiopathic hypercalciuria in patients with urinary calculosis].
    Noronha IL; Andriolo A; Lucon AM; Wroclawski ER; Chade J; Borelli A; Leite MO; Sabbaga E; Arap S
    Rev Paul Med; 1989; 107(1):19-24. PubMed ID: 2616974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in urinary composition of calcium oxalate stone formers.
    Rahman B; Rahman MA
    Biomed Pharmacother; 1986; 40(3):108-10. PubMed ID: 3742009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urine composition in patients with urolithiasis during treatment with magnesium oxide.
    Tiselius HG; Ahlstrand C; Larsson L
    Urol Res; 1980; 8(4):197-206. PubMed ID: 7222314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical studies on recurrence of urolithiasis. (2) Hypercalciuria and recurrence of urolithiasis].
    Murayama T; Taguchi H
    Hinyokika Kiyo; 1987 Nov; 33(11):1766-71. PubMed ID: 3445858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Should recurrent calcium oxalate stone formers become vegetarians?
    Robertson WG; Peacock M; Heyburn PJ; Hanes FA; Rutherford A; Clementson E; Swaminathan R; Clark PB
    Br J Urol; 1979 Dec; 51(6):427-31. PubMed ID: 534817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rice bran treatment for hypercalciuric patients with urinary calculous disease.
    Ohkawa T; Ebisuno S; Kitagawa M; Morimoto S; Miyazaki Y
    J Urol; 1983 May; 129(5):1009-11. PubMed ID: 6304355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic risk factors in pediatric and adult calcium oxalate urinary stone formers: is there any difference?
    Tefekli A; Esen T; Ziylan O; Erol B; Armagan A; Ander H; Akinci M
    Urol Int; 2003; 70(4):273-7. PubMed ID: 12740490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Wheat bran in the selective therapy of absorptive hypercalciuria: a study performed on 18 lithiasic patients.
    Tizzani A; Casetta G; Piana P; Vercelli D
    J Urol; 1989 Oct; 142(4):1018-20. PubMed ID: 2552183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Studies of urinary risk factors in urolithiasis].
    Ebisuno S; Kitagawa M; Morimoto S; Miyazaki Y; Minakata S; Yasukawa S; Fukatani T; Ohkawa T
    Hinyokika Kiyo; 1985 Jan; 31(1):1-15. PubMed ID: 3993484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of urinary oxalate excretion in urolithiasis patients with and without hypercalciuria.
    Koide T; Bowyer RC; Brockis JG
    Br J Urol; 1985 Oct; 57(5):505-9. PubMed ID: 4063729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cause of idiopathic calcium stone disease: hypercalciuria or hyperoxaluria?
    Robertson WG; Peacock M
    Nephron; 1980; 26(3):105-10. PubMed ID: 7412965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unprocessed bran and intermittent thiazide therapy in prevention of recurrent urinary calcium stones.
    Ala-Opas M; Elomaa I; Porkka L; Alfthan O
    Scand J Urol Nephrol; 1987; 21(4):311-4. PubMed ID: 2832935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Promoters and inhibitors of calcium urolithiasis in children.
    Lama G; Carbone MG; Marrone N; Russo P; Spagnuolo G
    Child Nephrol Urol; 1990; 10(2):81-4. PubMed ID: 2253256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of overweight and obesity on the urinary excretion of promoters and inhibitors of stone formation in stone formers.
    Negri AL; Spivacow FR; Del Valle EE; Forrester M; Rosende G; Pinduli I
    Urol Res; 2008 Dec; 36(6):303-7. PubMed ID: 18985334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.